Products
Companies
News
About
About
FAQ
Contact
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
QP-Brain
QP-Brain
Quibim
QP-Brain is a medical image processing application intended for automatic labeling and volumetric quantification of segmentable brain structures and White matter hyperintensities (WMH) from a set of MR images. Volumetric measurements may be compared to reference percentile data. The application is used by trained medical professionals, such as radiologists and neuroradiologists, as well as by clinical researchers, as a support tool in the assessment of structural MRIs.
Information source:
Vendor
Last updated:
January 30, 2024
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
QP-Brain
Company
Quibim
Subspeciality
Neuro
Modality
MR
Disease targeted
Alzheimer’s Disease, Frontotemporal dementia, Mild Cognitive Impariment (MCI), Multiple Sclerosis
Key-features
Brain segmentation, volume calculation, white matter hyperintensities quantification
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps)
Technical Specifications
Data characteristics
Population
Patients with suspected or confirmed conditions associated with brain atrophy/white matter hyperintensities such as neurodegenerative diseases.
Input
3D T1w gradient echo, T2 FLAIR
Input format
DICOM
Output
Segmentation and quantification of grey matter, white matter, and CSF and their parcellation in several anatomical subregions. Segmentation and quantification of white matter hyperintensities.
Output format
DICOM PDF
Technology
Integration
Integration in standard reading environment (PACS)
Deployment
Cloud-based
Trigger for analysis
Automatically, right after the image acquisition
Processing time
Regulatory
Certification
CE
Certified, Class IIa
, MDR
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
QP-Brain® is a medical image processing application intended for automatic labeling and volumetric quantification of segmentable brain structures and white matter hyperintensities (WMH) from a set of MR images.
Market
Market presence
On market since
12-2023
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Subscription
Based on
Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study
(read)
Non-peer reviewed papers on performance
Other relevant papers
Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool
(read)